Summary of Study ST000859
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000575. The data can be accessed directly via it's Project DOI: 10.21228/M8BM2Z This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST000859 |
| Study Title | Targeted Galactosyl Sphingolipid Concentration in Kallikrein 6 Mice after SCI |
| Study Summary | Targeted Galactosyl Sphingolipids in Kallikrein 6 Mice after SCI. The samples submitted are purified myelin preparations from the postnatal day 21, 60, or 90 mouse spinal cord (SC). There are 12 samples total in Project 3, n=3 for K6+/+ or K6-/- at either P21 or P90. |
| Institute | Mayo Clinic |
| Last Name | Scarisbrick |
| First Name | Isobel |
| Address | 200 First Street SW, Rochester, MN 55905 |
| scarisbrick.isobel@mayo.edu | |
| Phone | 507-284-0124 |
| Submit Date | 2017-08-10 |
| Analysis Type Detail | LC-MS |
| Release Date | 2021-02-17 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Mouse; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | group |
|---|---|---|
| SA047618 | ms6025-18 | K6-/- |
| SA047619 | ms6025-19 | K6-/- |
| SA047620 | ms6025-20 | K6-/- |
| SA047621 | ms6025-17 | K6-/- |
| SA047622 | ms6025-11 | K6-/- |
| SA047623 | ms6025-12 | K6-/- |
| SA047624 | ms6025-13 | K6-/- |
| SA047625 | ms6025-14 | K6-/- |
| SA047626 | ms6025-15 | K6-/- |
| SA047627 | ms6025-16 | K6-/- |
| SA047608 | ms6025-9 | K6+/+ |
| SA047609 | ms6025-10 | K6+/+ |
| SA047610 | ms6025-1 | K6+/+ |
| SA047611 | ms6025-7 | K6+/+ |
| SA047612 | ms6025-8 | K6+/+ |
| SA047613 | ms6025-6 | K6+/+ |
| SA047614 | ms6025-2 | K6+/+ |
| SA047615 | ms6025-4 | K6+/+ |
| SA047616 | ms6025-3 | K6+/+ |
| SA047617 | ms6025-5 | K6+/+ |
| Showing results 1 to 20 of 20 |
